Reumuth Mary
CHIEF FINANCIAL OFFICER
Reumuth Mary has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Oct 24, 2025.
On the most recent filing, Reumuth Mary is listed as CHIEF FINANCIAL OFFICER at KALA BIO, Inc. Inside the rolling window, Reumuth Mary reported no open-market purchases and 2 open-market sales totaling $28K in KALA. The largest disclosed transaction in the window is a sale of 32,230 KALA shares on Oct 22, 2025, worth $27K.
Companies traded
Other insiders at KALA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$28K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Reumuth Mary made?
Reumuth Mary has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2025.
Which companies does Reumuth Mary trade?
Reumuth Mary has filed SEC Form 4 disclosures for 1 company, including KALA.
When was Reumuth Mary's most recent SEC Form 4 filing?
Reumuth Mary's most recent SEC Form 4 filing on Tracefour is dated Oct 24, 2025.
What is Reumuth Mary's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Reumuth Mary is listed as CHIEF FINANCIAL OFFICER.
What is Reumuth Mary's total buy and sell value in the current window?
Inside the rolling retention window, Reumuth Mary bought $0 and sold $28K based on SEC Form 4 filings.
What was Reumuth Mary's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 32,230 KALA shares on 2025-10-22, worth $27K, per SEC Form 4 filings.